Drug Shortage Report for OMNIPAQUE 350
Report ID | 217731 |
Drug Identification Number | 02172755 |
Brand name | OMNIPAQUE 350 |
Common or Proper name | Iohexal Injection USP |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | IOHEXOL |
Strength(s) | 755MG |
Dosage form(s) | SOLUTION |
Route of administration | ORAL INTRAVASCULAR INTRAVASCULAR |
Packaging size | 500 mL |
ATC code | V08AB |
ATC description | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-02-15 |
Actual start date | |
Estimated end date | 2024-02-20 |
Actual end date | 2024-02-14 |
Shortage status | Avoided shortage |
Updated date | 2024-02-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-02-14 | French | Compare |
v6 | 2024-02-14 | English | Compare |
v5 | 2024-02-09 | French | Compare |
v4 | 2024-02-09 | English | Compare |
v3 | 2024-02-07 | English | Compare |
v2 | 2024-01-30 | French | Compare |
v1 | 2024-01-30 | English | Compare |
Showing 1 to 7 of 7